Balyasny Asset Management LLC Adma Biologics, Inc. Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
A detailed history of Balyasny Asset Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 59,342 shares of ADMA stock, worth $665,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,342
Previous 32,211
84.23%
Holding current value
$665,223
Previous $145,000
169.66%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ADMA
# of Institutions
224Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$142 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$118 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$117 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$87.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.2B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...